Established and experimental medical therapy of pulmonary sarcoidosis

Robert P. Baughman, Hilario Nunes, Nadera J. Sweiss, Elyse E. Lower

Source: Eur Respir J 2013; 41: 1424-1438
Journal Issue: June

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert P. Baughman, Hilario Nunes, Nadera J. Sweiss, Elyse E. Lower. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J 2013; 41: 1424-1438

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema
Source: Eur Respir J 2002; 20: Suppl. 38, 376s
Year: 2002

Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015



Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Application of psychotherapy in medical treatment of patients with first revealed pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Limitations of immune-based diagnostics in patients suspected for pulmonary tuberculosis
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009


Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Source: Eur Respir J 2016; 47: 45-68
Year: 2016




Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
Source: Guideline 2016
Year: 2016


Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects
Year: 2011


Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient
Source: Eur Respir Rev 2011; 20: 114-117
Year: 2011



Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Current medical treatment of pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Current medical treatment of pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012



Clinical conundrums in pulmonary embolism treatment
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012


Issues related to the management and therapy of paediatric pulmonary hypertension
Source: Eur Respir Rev 2010 19: 331-339
Year: 2010